Alloy Therapeutics
Alloy Therapeutics is a biotech company that provides tools, technologies, and services to the drug discovery community, focusing on therapeutic biologics and antibody discovery. They facilitate access to advanced platforms and innovative solutions for biotech and pharmaceutical partners.
Headquarters
Lexington, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Alloy Therapeutics is a fully integrated Product Development Organization (PDO) that partners with biotech, pharma, academic, and sovereign organizations to advance drug discovery and development across multiple modalities, including antibodies and multispecifics, TCR mimics, genetic medicines, pharmacology, and cell therapies. The company leverages proprietary AI/ML platforms, real-world data, and tech-enabled services spanning discovery through clinical development to deliver therapeutics with speed and capital efficiency. Alloy also operates specialized subsidiaries, including 82VS for asset-centric venture building and Spannerwerks for early clinical development support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alloy Therapeutics.
Alloy Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Research Associate
Orion Pharma
Research Associate
Orion
Senior Scientist I, Biologics In Vitro Technologies
AbbVie
Scientist/Sr Scientist, Display Technology (Contract)
Xaira Therapeutics
Scientist R&D Molecular Design (m/f/d)
Arizona State Jobs
Senior Scientist - Display Technologies (Antibody Discovery)
Cancer Research UK